Position in VCYT
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$42,579
+$4,056 QoQ
Shares Held
725
-39.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#284
of 365 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bayforest Capital Ltd holds $1,686,743 across 12 Diagnostics & Research names. VCYT ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
721 | $361,480 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
1,570 | $356,060 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
595 | $315,106 | |
| 4 | LH |
Labcorp Holdings Inc.
|
585 | $163,800 | |
| 5 | NTRA |
Natera, Inc.
|
551 | $149,568 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
223 | $117,396 | |
| 7 | A |
Agilent Technologies, Inc.
|
832 | $110,514 | |
| 8 | VCYT |
Veracyte, Inc.
This page
|
725 | $42,579 |
All Filings in VCYT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,579 | 725 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $38,523 | 1,196 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $106,555 | 2,531 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $515,808 | 15,025 | Shares | Sole | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||